TGTX
Tg Therapeutics Inc
$13.66
Earnings Summary
Revenue | $43.97Mn |
Net Profits | $-14.42Mn |
Net Profit Margins | -32.79% |
Highlights
Tg Therapeutics Inc’s revenue jumped 54863.75% since last year same period to $43.97Mn in the Q4 2023. On a quarterly growth basis, Tg Therapeutics Inc has generated -73.48% fall in its revenue since last 3-months.
Tg Therapeutics Inc’s net profit jumped 73.27% since last year same period to $-14.42Mn in the Q4 2023. On a quarterly growth basis, Tg Therapeutics Inc has generated -112.65% fall in its net profits since last 3-months.
Tg Therapeutics Inc’s net profit margin jumped 99.95% since last year same period to -32.79% in the Q4 2023. On a quarterly growth basis, Tg Therapeutics Inc has generated -147.72% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Tg Therapeutics Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.04 |
EPS Estimate Current Year | -0.04 |
Highlights
Tg Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.04 - a 60% jump from last quarter’s estimates.
Tg Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.04.
Key Ratios
Key ratios of the Tg Therapeutics Inc post its Q4 2023 earnings
Earning Per Share (EPS) | -0.1 |
Highlights
Tg Therapeutics Inc’s earning per share (EPS) jumped 74.36% since last year same period to -0.1 in the Q4 2023. This indicates that the Tg Therapeutics Inc has generated 74.36% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-02-29 | -0.1 | -0.1 | 0% |
2023-05-08 | -0.37 | -0.28 | 24.32% |
2023-11-06 | 0.12 | 0.73 | 508.33% |
2023-08-04 | -0.25 | -0.34 | -36% |
₹0 US Stocks a/c Opening Fee